Close

Eli Lilly (LLY) to Acquire CoLucid Pharmaceuticals (CLCD) for $960M

January 18, 2017 6:47 AM EST Send to a Friend
Eli Lilly and Company (NYSE: LLY) and CoLucid Pharmaceuticals, Inc. (Nasdaq: CLCD) today announced an agreement for Lilly to acquire ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login